ID NUMBL_HUMAN Reviewed; 609 AA. AC Q9Y6R0; Q7Z4J9; DT 01-JUN-2001, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 27-MAR-2024, entry version 190. DE RecName: Full=Numb-like protein; DE AltName: Full=Numb-related protein; DE Short=Numb-R; GN Name=NUMBL; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=9303539; DOI=10.1101/gad.11.17.2239; RA Salcini A.E., Confalonieri S., Doria M., Santolini E., Tassi E., RA Minenkova O., Cesareni G., Pelicci P.G., Di Fiore P.P.; RT "Binding specificity and in vivo targets of the EH domain, a novel protein- RT protein interaction module."; RL Genes Dev. 11:2239-2249(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-609. RC TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 42-609. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=17081983; DOI=10.1016/j.cell.2006.09.026; RA Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.; RT "Global, in vivo, and site-specific phosphorylation dynamics in signaling RT networks."; RL Cell 127:635-648(2006). RN [5] RP FUNCTION, INTERACTION WITH MAP3K7IP2, AND SUBCELLULAR LOCATION. RX PubMed=18299187; DOI=10.1016/j.cellsig.2008.01.015; RA Ma Q., Zhou L., Shi H., Huo K.; RT "NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF- RT kappaB activation."; RL Cell. Signal. 20:1044-1051(2008). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-279, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [7] RP FUNCTION, AND INTERACTION WITH TRAF6. RX PubMed=20079715; DOI=10.1016/j.bbrc.2010.01.037; RA Zhou L., Ma Q., Shi H., Huo K.; RT "NUMBL interacts with TRAF6 and promotes the degradation of TRAF6."; RL Biochem. Biophys. Res. Commun. 392:409-414(2010). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224; SER-228 AND SER-263, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 60-204. RG Structural genomics consortium (SGC); RT "Human numb-like protein, phosphotyrosine interaction domain."; RL Submitted (FEB-2009) to the PDB data bank. CC -!- FUNCTION: Plays a role in the process of neurogenesis. Required CC throughout embryonic neurogenesis to maintain neural progenitor cells, CC also called radial glial cells (RGCs), by allowing their daughter cells CC to choose progenitor over neuronal cell fate. Not required for the CC proliferation of neural progenitor cells before the onset of embryonic CC neurogenesis. Also required postnatally in the subventricular zone CC (SVZ) neurogenesis by regulating SVZ neuroblasts survival and ependymal CC wall integrity. Negative regulator of NF-kappa-B signaling pathway. The CC inhibition of NF-kappa-B activation is mediated at least in part, by CC preventing MAP3K7IP2 to interact with polyubiquitin chains of TRAF6 and CC RIPK1 and by stimulating the 'Lys-48'-linked polyubiquitination and CC degradation of TRAF6 in cortical neurons. {ECO:0000269|PubMed:18299187, CC ECO:0000269|PubMed:20079715}. CC -!- SUBUNIT: Interacts (via PTB domain) with MAP3K7IP2 (via C-terminal). CC Interacts (via C-terminal) with TRAF6 (via TRAF domains). Associates CC with EPS15 and NOTCH1. {ECO:0000269|PubMed:18299187, CC ECO:0000269|PubMed:20079715}. CC -!- INTERACTION: CC Q9Y6R0; Q00535: CDK5; NbExp=3; IntAct=EBI-945925, EBI-1041567; CC Q9Y6R0; O94985-2: CLSTN1; NbExp=3; IntAct=EBI-945925, EBI-16041593; CC Q9Y6R0; P00533: EGFR; NbExp=2; IntAct=EBI-945925, EBI-297353; CC Q9Y6R0; P27986-2: PIK3R1; NbExp=3; IntAct=EBI-945925, EBI-9090282; CC Q9Y6R0; Q9NWB1: RBFOX1; NbExp=2; IntAct=EBI-945925, EBI-945906; CC Q9Y6R0; Q6PJ21: SPSB3; NbExp=5; IntAct=EBI-945925, EBI-3937206; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Note=Symmetrically CC distributed throughout the cytoplasm in non dividing neuroblasts of the CC CNS. {ECO:0000250}. CC -!- DOMAIN: The PTB domain is necessary for the inhibition of MAP3K7IP2- CC mediated activation of NF-kappa-B. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF015041; AAD01549.1; -; mRNA. DR EMBL; BC001794; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; BT009807; AAP88809.1; -; mRNA. DR CCDS; CCDS12561.1; -. DR RefSeq; NP_001276908.1; NM_001289979.1. DR RefSeq; NP_001276909.1; NM_001289980.2. DR RefSeq; NP_004747.1; NM_004756.4. DR PDB; 3F0W; X-ray; 2.70 A; A=60-204. DR PDBsum; 3F0W; -. DR AlphaFoldDB; Q9Y6R0; -. DR SMR; Q9Y6R0; -. DR BioGRID; 114677; 112. DR ELM; Q9Y6R0; -. DR IntAct; Q9Y6R0; 50. DR MINT; Q9Y6R0; -. DR STRING; 9606.ENSP00000252891; -. DR GlyCosmos; Q9Y6R0; 1 site, 1 glycan. DR GlyGen; Q9Y6R0; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q9Y6R0; -. DR MetOSite; Q9Y6R0; -. DR PhosphoSitePlus; Q9Y6R0; -. DR BioMuta; NUMBL; -. DR DMDM; 14194976; -. DR EPD; Q9Y6R0; -. DR jPOST; Q9Y6R0; -. DR MassIVE; Q9Y6R0; -. DR MaxQB; Q9Y6R0; -. DR PaxDb; 9606-ENSP00000252891; -. DR PeptideAtlas; Q9Y6R0; -. DR ProteomicsDB; 86771; -. DR Pumba; Q9Y6R0; -. DR Antibodypedia; 30612; 304 antibodies from 32 providers. DR DNASU; 9253; -. DR Ensembl; ENST00000252891.8; ENSP00000252891.3; ENSG00000105245.9. DR GeneID; 9253; -. DR KEGG; hsa:9253; -. DR MANE-Select; ENST00000252891.8; ENSP00000252891.3; NM_004756.5; NP_004747.1. DR UCSC; uc002oon.5; human. DR AGR; HGNC:8061; -. DR CTD; 9253; -. DR DisGeNET; 9253; -. DR GeneCards; NUMBL; -. DR HGNC; HGNC:8061; NUMBL. DR HPA; ENSG00000105245; Low tissue specificity. DR MIM; 604018; gene. DR neXtProt; NX_Q9Y6R0; -. DR OpenTargets; ENSG00000105245; -. DR PharmGKB; PA31846; -. DR VEuPathDB; HostDB:ENSG00000105245; -. DR eggNOG; KOG3537; Eukaryota. DR GeneTree; ENSGT00940000160957; -. DR InParanoid; Q9Y6R0; -. DR OMA; PWMSRSA; -. DR OrthoDB; 2913102at2759; -. DR PhylomeDB; Q9Y6R0; -. DR TreeFam; TF314159; -. DR PathwayCommons; Q9Y6R0; -. DR SignaLink; Q9Y6R0; -. DR BioGRID-ORCS; 9253; 111 hits in 1157 CRISPR screens. DR ChiTaRS; NUMBL; human. DR EvolutionaryTrace; Q9Y6R0; -. DR GeneWiki; NUMBL; -. DR GenomeRNAi; 9253; -. DR Pharos; Q9Y6R0; Tbio. DR PRO; PR:Q9Y6R0; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q9Y6R0; Protein. DR Bgee; ENSG00000105245; Expressed in pancreatic ductal cell and 186 other cell types or tissues. DR ExpressionAtlas; Q9Y6R0; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0034332; P:adherens junction organization; IEA:Ensembl. DR GO; GO:0007409; P:axonogenesis; IEA:Ensembl. DR GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB. DR GO; GO:0021670; P:lateral ventricle development; ISS:UniProtKB. DR GO; GO:0007399; P:nervous system development; TAS:ProtInc. DR GO; GO:0021849; P:neuroblast division in subventricular zone; ISS:UniProtKB. DR GO; GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB. DR GO; GO:0019538; P:protein metabolic process; IDA:UniProtKB. DR CDD; cd01268; PTB_Numb; 1. DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1. DR InterPro; IPR016698; Numb/numb-like. DR InterPro; IPR010449; Numb_domain. DR InterPro; IPR011993; PH-like_dom_sf. DR InterPro; IPR006020; PTB/PI_dom. DR PANTHER; PTHR47368; NUMB; 1. DR PANTHER; PTHR47368:SF4; NUMB-LIKE PROTEIN; 1. DR Pfam; PF06311; NumbF; 1. DR Pfam; PF00640; PID; 1. DR PIRSF; PIRSF017607; Numb/numb-like; 1. DR SMART; SM00462; PTB; 1. DR SUPFAM; SSF50729; PH domain-like; 1. DR PROSITE; PS01179; PID; 1. DR Genevisible; Q9Y6R0; HS. PE 1: Evidence at protein level; KW 3D-structure; Cytoplasm; Developmental protein; Neurogenesis; KW Phosphoprotein; Reference proteome; Ubl conjugation pathway. FT CHAIN 1..609 FT /note="Numb-like protein" FT /id="PRO_0000057999" FT DOMAIN 74..223 FT /note="PID" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00148" FT REGION 1..68 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 223..283 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 372..421 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 434..464 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 537..609 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 15..29 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 52..68 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 434..451 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 542..573 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 224 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 228 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 263 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 279 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 411 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O08919" FT TURN 64..66 FT /evidence="ECO:0007829|PDB:3F0W" FT HELIX 67..74 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 78..91 FT /evidence="ECO:0007829|PDB:3F0W" FT HELIX 96..107 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 114..120 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 122..129 FT /evidence="ECO:0007829|PDB:3F0W" FT TURN 130..132 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 135..140 FT /evidence="ECO:0007829|PDB:3F0W" FT HELIX 141..143 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 144..149 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 156..163 FT /evidence="ECO:0007829|PDB:3F0W" FT TURN 164..167 FT /evidence="ECO:0007829|PDB:3F0W" FT STRAND 168..179 FT /evidence="ECO:0007829|PDB:3F0W" FT HELIX 181..201 FT /evidence="ECO:0007829|PDB:3F0W" SQ SEQUENCE 609 AA; 64891 MW; 69458D161B60F4B4 CRC64; MSRSAAASGG PRRPERHLPP APCGAPGPPE TCRTEPDGAG TMNKLRQSLR RRKPAYVPEA SRPHQWQADE DAVRKGTCSF PVRYLGHVEV EESRGMHVCE DAVKKLKAMG RKSVKSVLWV SADGLRVVDD KTKDLLVDQT IEKVSFCAPD RNLDKAFSYI CRDGTTRRWI CHCFLALKDS GERLSHAVGC AFAACLERKQ RREKECGVTA AFDASRTSFA REGSFRLSGG GRPAEREAPD KKKAEAAAAP TVAPGPAQPG HVSPTPATTS PGEKGEAGTP VAAGTTAAAI PRRHAPLEQL VRQGSFRGFP ALSQKNSPFK RQLSLRLNEL PSTLQRRTDF QVKGTVPEME PPGAGDSDSI NALCTQISSS FASAGAPAPG PPPATTGTSA WGEPSVPPAA AFQPGHKRTP SEAERWLEEV SQVAKAQQQQ QQQQQQQQQQ QQQQQQAASV APVPTMPPAL QPFPAPVGPF DAAPAQVAVF LPPPHMQPPF VPAYPGLGYP PMPRVPVVGI TPSQMVANAF CSAAQLQPQP ATLLGKAGAF PPPAIPSAPG SQARPRPNGA PWPPEPAPAP APELDPFEAQ WAALEGKATV EKPSNPFSGD LQKTFEIEL //